SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
The One Simple Reason Investors Should Still Steer Clear Away From Valeant
August 25, 2017
 · 
1 min read
Debt Ridden Valeant Dumps Another Asset in $190 Million Cash Deal
Deals
Debt-Ridden Valeant Dumps Another Asset in $190 Million Cash Deal
July 17, 2017
 · 
3 min read
Deals
Valeant: Was iNova Pharma Sale The Worst Deal Ever?
June 19, 2017
 · 
1 min read
Business
The Not-So-Subtle Reason Behind Valeant’ 30% Rise In May
June 8, 2017
 · 
1 min read
Debt Ridden Valeant Dumps Another Asset in $190 Million Cash Deal
Deals
Debt-Ridden Valeant Nears Sale of Its $2 Billion Eye Care Biz Bausch & Lomb
June 7, 2017
 · 
2 min read
68 Hedge Funds Buy Valeant For The First Time
May 31, 2017
 · 
1 min read
Policy
Why Valeant CEO Thinks Johnson & Johnson Should Foot The Bill For Their Talc Defense
May 25, 2017
 · 
1 min read
3 Biotechs That Could be Taken Out This Quarter
Genetown
Short Seller Who Unraveled Valeant Zeroes in On This Massachusetts Biotech
May 16, 2017
 · 
2 min read
Is This The Real Reason Valeant’s Shares Are Skyrocketing?
May 12, 2017
 · 
1 min read
Load More
IN THE PRESS
Valeant Announces Redemption of $150 Million Aggregate Principal Amount of Its Outstanding 6.375% Senior Unsecured Notes Due 2020
April 12, 2018
 · 
3 min read
Policy
Arbitral Tribunal Decides In Favor Of Valeant In UCERIS Arbitration
April 12, 2018
 · 
3 min read
Drug Development
Ortho Dermatologics Announces Publication Of Pivotal Efficacy And Safety Data For Psoriasis Treatment DUOBRII™ In The Journal of the American Academy of Dermatology
April 9, 2018
 · 
4 min read
Business
Valeant Announces Fourth-Quarter And Full-Year 2017 Results And Provides 2018 Guidance
February 28, 2018
 · 
96 min read
Valeant Announces Redemption Of Remaining $71 Million Aggregate Principal Amount Of Its Outstanding 7.00% Senior Unsecured Notes Due 2020
February 28, 2018
 · 
3 min read
Business
Valeant Will Release Fourth-Quarter and Full-Year 2017 Financial Results On February 28
February 6, 2018
 · 
1 min read
Intrexon Enters Into $100M Preferred Stock Equity
Valeant to Shave an Additional $200M From Its Mountain of Debt
January 25, 2018
 · 
2 min read
Valeant Pays Down $300M of Senior Secured Term Loans
January 3, 2018
 · 
2 min read
Policy
Kessler Topaz Represents Investors in $290M Total Settlement Recovery Reached with Valeant Pharmaceuticals and Bill Ackman’s Pershing Square Over Insider Trading Claims
January 2, 2018
 · 
2 min read
Valeant Completes Sale of Sprout Pharma Subsidiary to Former Shareholders of Sprout Pharma
December 20, 2017
 · 
2 min read
Load More